Open AccessA Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species
Author(s) -
Puiian Wong,
Zheng Lv,
Jinglan Li,
Qiushi Wei,
Liangliang Xu,
Bin Fang,
Yiwen Luo,
Mincong He
Publication year - 2022
Publication title -
oxidative medicine and cellular longevity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.494
H-Index - 93
eISSN - 1942-0900
pISSN - 1942-0994
DOI - 10.1155/2022/5982014
Subject(s) - rankl , osteoclast , chemistry , bone resorption , nf κb , osteoblast , in vivo , osteoporosis , microbiology and biotechnology , ovariectomized rat , bone remodeling , reactive oxygen species , signal transduction , cancer research , pharmacology , in vitro , biochemistry , medicine , activator (genetics) , biology , receptor , hormone
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom